Vivos Therapeutics (VVOS) said Wednesday it struck a deal to buy the operating assets of The Sleep Center of Nevada for up to $9 million, including $6 million in cash and $1.5 million in shares.
The transaction, expected to close in Q2 or Q3, does not require Vivos shareholder approval, the company said. It plans to secure funding with a senior debt facility, and potential equity financing.
With the acquisition, the company said it plans to make its treatments for obstructive sleep apnea available to thousands of patients in the greater Las Vegas metro area.
Price: 2.10, Change: -0.09, Percent Change: -4.11
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.